Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000930413-09-000305
Filing Date
2009-01-16
Accepted
2009-01-16 17:23:10
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 c56380_10ka.htm 10-K/A 34568
2 c56380_ex31-1.htm EX-31.1 7228
3 c56380_ex31-2.htm EX-31.2 7084
4 c56380_ex32-1.htm EX-32.1 3508
5 c56380_ex32-2.htm EX-32.2 3456
  Complete submission text file 0000930413-09-000305.txt   57235
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-15697 | Film No.: 09532364
SIC: 2834 Pharmaceutical Preparations